463 related articles for article (PubMed ID: 32314272)
1. Alanyl-tRNA synthetase 1 (AARS1) gene mutation in a family with intermediate Charcot-Marie-Tooth neuropathy.
Lee AJ; Nam DE; Choi YJ; Nam SH; Choi BO; Chung KW
Genes Genomics; 2020 Jun; 42(6):663-672. PubMed ID: 32314272
[TBL] [Abstract][Full Text] [Related]
2. A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).
McLaughlin HM; Sakaguchi R; Giblin W; ; Wilson TE; Biesecker L; Lupski JR; Talbot K; Vance JM; Züchner S; Lee YC; Kennerson M; Hou YM; Nicholson G; Antonellis A
Hum Mutat; 2012 Jan; 33(1):244-53. PubMed ID: 22009580
[TBL] [Abstract][Full Text] [Related]
3. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and proteome modifications in two Charcot-Marie-Tooth families with the AARS1 Arg326Trp mutation.
Høyer H; Busk ØL; Esbensen QY; Røsby O; Hilmarsen HT; Russell MB; Nyman TA; Braathen GJ; Nilsen HL
BMC Neurol; 2022 Aug; 22(1):299. PubMed ID: 35971119
[TBL] [Abstract][Full Text] [Related]
5. Variants of aminoacyl-tRNA synthetase genes in Charcot-Marie-Tooth disease: A Korean cohort study.
Nam DE; Park JH; Park CE; Jung NY; Nam SH; Kwon HM; Kim HS; Kim SB; Son WS; Choi BO; Chung KW
J Peripher Nerv Syst; 2022 Mar; 27(1):38-49. PubMed ID: 34813128
[TBL] [Abstract][Full Text] [Related]
6. A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease.
Latour P; Thauvin-Robinet C; Baudelet-Méry C; Soichot P; Cusin V; Faivre L; Locatelli MC; Mayençon M; Sarcey A; Broussolle E; Camu W; David A; Rousson R
Am J Hum Genet; 2010 Jan; 86(1):77-82. PubMed ID: 20045102
[TBL] [Abstract][Full Text] [Related]
7. Alanyl-tRNA synthetase mutation in a family with dominant distal hereditary motor neuropathy.
Zhao Z; Hashiguchi A; Hu J; Sakiyama Y; Okamoto Y; Tokunaga S; Zhu L; Shen H; Takashima H
Neurology; 2012 May; 78(21):1644-9. PubMed ID: 22573628
[TBL] [Abstract][Full Text] [Related]
8. Hypermorphic and hypomorphic AARS alleles in patients with CMT2N expand clinical and molecular heterogeneities.
Weterman MAJ; Kuo M; Kenter SB; Gordillo S; Karjosukarso DW; Takase R; Bronk M; Oprescu S; van Ruissen F; Witteveen RJW; Bienfait HME; Breuning M; Verhamme C; Hou YM; de Visser M; Antonellis A; Baas F
Hum Mol Genet; 2018 Dec; 27(23):4036-4050. PubMed ID: 30124830
[TBL] [Abstract][Full Text] [Related]
9. CMT2N-causing aminoacylation domain mutants enable Nrp1 interaction with AlaRS.
Sun L; Wei N; Kuhle B; Blocquel D; Novick S; Matuszek Z; Zhou H; He W; Zhang J; Weber T; Horvath R; Latour P; Pan T; Schimmel P; Griffin PR; Yang XL
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753480
[TBL] [Abstract][Full Text] [Related]
10. Alanyl-tRNA Synthetase 1 Gene Variants in Hereditary Neuropathy: Genotype and Phenotype Overview.
Setlere S; Jurcenko M; Gailite L; Rots D; Kenina V
Neurol Genet; 2022 Oct; 8(5):e200019. PubMed ID: 36092982
[TBL] [Abstract][Full Text] [Related]
11. MFN2 point mutations occur in 3.4% of Charcot-Marie-Tooth families. An investigation of 232 Norwegian CMT families.
Braathen GJ; Sand JC; Lobato A; Høyer H; Russell MB
BMC Med Genet; 2010 Mar; 11():48. PubMed ID: 20350294
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy.
Claeys KG; Züchner S; Kennerson M; Berciano J; Garcia A; Verhoeven K; Storey E; Merory JR; Bienfait HM; Lammens M; Nelis E; Baets J; De Vriendt E; Berneman ZN; De Veuster I; Vance JM; Nicholson G; Timmerman V; De Jonghe P
Brain; 2009 Jul; 132(Pt 7):1741-52. PubMed ID: 19502294
[TBL] [Abstract][Full Text] [Related]
13. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
[TBL] [Abstract][Full Text] [Related]
14. Peripheral Myelin Protein 22 Gene Mutations in Charcot-Marie-Tooth Disease Type 1E Patients.
Jung NY; Kwon HM; Nam DE; Tamanna N; Lee AJ; Kim SB; Choi BO; Chung KW
Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886002
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease.
Sevilla T; Lupo V; Martínez-Rubio D; Sancho P; Sivera R; Chumillas MJ; García-Romero M; Pascual-Pascual SI; Muelas N; Dopazo J; Vílchez JJ; Palau F; Espinós C
Brain; 2016 Jan; 139(Pt 1):62-72. PubMed ID: 26497905
[TBL] [Abstract][Full Text] [Related]
16. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
17. Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.
Berciano J; García A; Gallardo E; Peeters K; Pelayo-Negro AL; Álvarez-Paradelo S; Gazulla J; Martínez-Tames M; Infante J; Jordanova A
J Neurol; 2017 Aug; 264(8):1655-1677. PubMed ID: 28364294
[TBL] [Abstract][Full Text] [Related]
18. Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations.
Griffin LB; Sakaguchi R; McGuigan D; Gonzalez MA; Searby C; Züchner S; Hou YM; Antonellis A
Hum Mutat; 2014 Nov; 35(11):1363-71. PubMed ID: 25168514
[TBL] [Abstract][Full Text] [Related]
19. Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland.
Bansagi B; Antoniadi T; Burton-Jones S; Murphy SM; McHugh J; Alexander M; Wells R; Davies J; Hilton-Jones D; Lochmüller H; Chinnery P; Horvath R
J Neurol; 2015 Aug; 262(8):1899-908. PubMed ID: 26032230
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
